Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients

Fig. 2

Left ventricular ejection fraction before and after chemotherapy for all chemotherapies containing anthracyclines. Note that a single patient can have received more than one chemotherapy containing anthracyclines. The diagonal line has slope 1, hence points above the line indicate a higher LVEF after chemotherapy, and vice versa. The number indicates the line of treatment of the chemotherapy that has been analyzed

Back to article page